Retail healthcare moves deeper into medical weight loss as demand for obesity treatments grows
New York, 17 February 2026 – Kroger Health, the healthcare arm of grocery giant Kroger, has upgraded its weight management program to give patients access to medical treatment options, including highly sought-after GLP-1 weight loss drugs. The move places Kroger alongside other major retailers offering easier access to prescription obesity medications in the United States.
In simple words, Kroger is now making it easier for people to explore doctor-guided weight loss treatments through its clinics and telehealth services. Patients enrolled in the updated program can consult healthcare professionals about options such as GLP-1 medications, which are widely known for helping with weight loss and blood sugar control.
The program will be offered through The Little Clinic, with visits starting at $99. Appointments will be available both in person and online, giving patients more flexibility in how they receive care.
Growing Demand for GLP-1 Weight Loss Drugs
GLP-1 medications have become extremely popular across the U.S. for managing obesity and diabetes. These drugs work by reducing appetite and helping patients feel full for longer periods. Kroger joins retail peer Costco Wholesale in offering access to this fast-growing class of treatments.
Some of the most well-known GLP-1 drugs include Wegovy from Novo Nordisk and Zepbound from Eli Lilly. Zepbound entered the U.S. market as a weight-loss drug in December last year, while Wegovy has been approved for obesity treatment since 2021.
Despite their effectiveness, these medications have faced supply shortages over the past year as manufacturers race to increase production. Cost has also been a major concern for patients. Monthly list prices for GLP-1 drugs often exceed $1,000, making them difficult to afford for many people, even with insurance coverage.
Affordability Remains a Key Challenge
A recent poll by the Kaiser Family Foundation found that about one in eight adults in the U.S. has used a GLP-1 drug for weight loss or related conditions. More than half of those users said affordability was a challenge, highlighting the financial barriers that still exist around these treatments.
Kroger Health’s expanded program aims to address part of this gap by offering structured medical guidance through a familiar retail healthcare setting. While the cost of the drugs themselves remains high, easier access to consultations may help patients better understand treatment options, insurance coverage, and long-term care plans.
Retail Healthcare on the Rise
Kroger Health currently operates over 2,200 pharmacies and 226 clinics across 35 states, making it one of the largest retail healthcare providers in the country. By expanding into medical weight management, the company is strengthening its role beyond traditional pharmacy services.
As demand for obesity treatment continues to rise, retail-based healthcare models like Kroger’s are expected to play a growing role in how Americans access weight loss care. The shift reflects a broader trend of bringing medical services closer to everyday locations, combining convenience with professional oversight.
